GREENLAND MINES LTD (GRML) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value |
| Current obligations | 1.21M USD | Liabilities, Current |
| Cash and equivalents | 9.30M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $1.21M | $9.30M | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $553.74K | $10.00M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $76.76K | $7.18M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $92.89K | $7.30M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $62.96K | $8.43M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $2.34M | $565.87K | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $1.25M | $63.74K | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $982.43K | $50.90K | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $898.56K | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $2.58M | $8.05K | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $2.31M | $172.53K | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $1.66M | $146.33K | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $1.35M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $64.54M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $506.24K | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $218.35K | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $69.30K | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $240.50K | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $8.51K | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |